Maintenance of lymphoid homeostasis is critical to avert diseases such as autoimmunity, lymphoma, and immunodeficiency. We propose to study a novel mechanism of T cell homeostasis?control of nutrient usage, or trophic level, by regulation of glucose uptake and the glucose transporter, Glutl. Lymphocytes require dynamic regulation of glucose uptake to allow both cell survival in a resting state and robust growth and proliferation in immune responses. We have shown that glucose uptake and metabolism are regulated events that can have a profound impact on T cell survival and function. We show that glucose uptake in both resting and activated T cells is tightly regulated in vitro by the cytokines interleukin 7 (IL7) and interleukin 2 (IL2), respectively. The in vivo signals and signaling mechanisms required for regulation of Glutl and the effects of altered glucose uptake on T cell size, survival, and function, however, remain uncertain. In this application, we propose to address these issues to bridge the fields of immunology and cellular metabolism. We will: (1) Determine the in vivo role of IL7 in regulation of Glutl expression and intracellular trafficking by adoptive transfer of T cells into IL7-/- hosts and conditional deletion of IL7R in mature T cells. (2) Identify signaling mechanisms that regulate Glutl expression and cell surface localization. The PI3K/Akt and Jak/STAT signaling pathways are activated by IL7 and IL2 and these pathways will be analyzed for their role in Glutl regulation in cell line and primary T cell models using RNAi, transgenic, and knockout approaches. (3) Examine the role of Glutl expression in T cell development and homeostasis using a T cell specific Glutl transgenic mouse model and in vitro RNAi of Glutl. The ability of Glutl expression to modulate lymphoma and autoimmunity observed in Akt transgenic mice will be investigated to determine how altered glucose uptake may affect disease. Together, these experiments will identify signals and signaling mechanisms that regulate T cell glucose uptake and determine the role of glucose uptake in T cell survival, activation, and diseases of the immune system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI063345-03
Application #
7336777
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Mallia, Conrad M
Project Start
2006-02-01
Project End
2011-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
3
Fiscal Year
2008
Total Cost
$371,495
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Ho, Ping-Chih; Bihuniak, Jessica Dauz; Macintyre, Andrew N et al. (2015) Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell 162:1217-28
Macintyre, Andrew N; Gerriets, Valerie A; Nichols, Amanda G et al. (2014) The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab 20:61-72
Cao, Yilin; Rathmell, Jeffrey C; Macintyre, Andrew N (2014) Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells. PLoS One 9:e104104
Gerriets, Valerie A; Rathmell, Jeffrey C (2012) Metabolic pathways in T cell fate and function. Trends Immunol 33:168-73
Michalek, Ryan D; Gerriets, Valerie A; Nichols, Amanda G et al. (2011) Estrogen-related receptor-? is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci U S A 108:18348-53
Coloff, Jonathan L; Mason, Emily F; Altman, Brian J et al. (2011) Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. J Biol Chem 286:5921-33
MacIver, Nancie J; Blagih, Julianna; Saucillo, Donte C et al. (2011) The liver kinase B1 is a central regulator of T cell development, activation, and metabolism. J Immunol 187:4187-98
Coloff, Jonathan L; Macintyre, Andrew N; Nichols, Amanda G et al. (2011) Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition. Cancer Res 71:5204-13
Michalek, Ryan D; Gerriets, Valerie A; Jacobs, Sarah R et al. (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol 186:3299-303
Michalek, Ryan D; Rathmell, Jeffrey C (2010) The metabolic life and times of a T-cell. Immunol Rev 236:190-202

Showing the most recent 10 out of 23 publications